Form 8-K - Current report:
SEC Accession No. 0001213900-25-058603
Filing Date
2025-06-27
Accepted
2025-06-27 07:59:08
Documents
12
Period of Report
2025-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0247272-8k_ostherap.htm   iXBRL 8-K 41864
  Complete submission text file 0001213900-25-058603.txt   212990

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ostx-20250626.xsd EX-101.SCH 3023
3 XBRL LABEL FILE ostx-20250626_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ostx-20250626_pre.xml EX-101.PRE 22364
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0247272-8k_ostherap_htm.xml XML 3811
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 251082250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)